Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: Epidermal hyperplasia and the involvement of immune cells characterize the clinical picture of psoriasis. Among the several factors involved, attention has been focused on sirtuin 1 (SIRT1) - a deacetylase endowed with a variety of functions including the control of metabolic and inflammatory processes-, and on nicotinamide phosphoribosyltransferase (NAMPT), important for SIRT1 activation and involved in inflammatory events. The aim of the study was to analyze changes of SIRT1 and NAMPT expression in psoriatic skin.

Patients And Methods: Samples from healthy controls and psoriatic patients were subjected to immunohistochemical analysis.

Results: A strong downregulation of SIRT1 expression was observed in skin samples from psoriatic patients compared to healthy controls. This was accompanied by a parallel reduction of adenosine monophosphate-activated kinase (AMPK) expression and, more strikingly, by the disappearance of cells immunolabeled for its active, phosphorylated form (pAMPK). In both cases, analysis of the distribution of immunopositive cells revealed a shift towards reduced intensity of staining. In contrast, NAMPT expression was upregulated in psoriatic samples in line with its pro-inflammatory role. This was again more visible with an intensity-based distribution analysis that evidenced a shift towards more intensely immunostained cell populations.

Conclusions: The present data correlate in the same samples the expression of SIRT1, pAMPK/AMPK and NAMPT in psoriasis and open the way for novel pharmacological targets in the treatment of the disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.advms.2022.07.001DOI Listing

Publication Analysis

Top Keywords

nampt expression
8
healthy controls
8
psoriatic patients
8
expression
6
nampt
5
psoriatic
5
sirt1
5
inverse correlation
4
correlation expression
4
expression ampk/sirt1
4

Similar Publications

NAMPT Is A Novel Inhibitor of Vascular Calcification in Chronic Kidney Disease.

Arterioscler Thromb Vasc Biol

September 2025

Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, China. (Q.D., X.Z., L.F., A.C., Z.L., Y.Y., J.Z., X.L., Y.L., J.Y.).

Background: Vascular calcification is very common in patients with chronic kidney disease and contributes to the increased risk of cardiovascular events. NAMPT (nicotinamide phosphoribosyltransferase), the rate-limiting enzyme in the salvage pathway of nicotinamide adenine dinucleotide, has been shown to exert an antiaging effect on vascular smooth muscle cells. However, whether NAMPT is involved in the regulation of vascular calcification remains unclear.

View Article and Find Full Text PDF

Multi-omics reveals mechanism of Qi-Po-Sheng-Mai granule in reducing atrial fibrillation susceptibility in aged rats.

Chin Med

September 2025

Department of Cardiovascular, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, 5 Beixiange Street, Xicheng District, Beijing, 100053, People's Republic of China.

Background: Atrial Fibrillation (AF) is the most common arrhythmia in clinical practice, and age is an independent risk factor for the development of AF. Qi-Po-Sheng-Mai granule (QPSM) has been used clinically to treat aging-related AF, however, its underlying mechanisms remain incompletely understood.

Methods: In this study, we established a D-galactose-induced aging rat model to evaluate the effects of QPSM on aging-related AF through electrocardiograms, echocardiography, and histopathological analysis.

View Article and Find Full Text PDF

Nicotinamide adenine dinucleotide (NAD) is a critical metabolic co-enzyme implicated in brain aging, and augmenting NAD levels in the aging brain is an attractive therapeutic strategy for neurodegeneration. However, the molecular mechanisms of brain NAD regulation are incompletely understood. In cardiac tissue, the circadian nuclear receptor REV-ERBα has been shown to regulate NAD via control of the NAD-producing enzyme NAMPT.

View Article and Find Full Text PDF

Integrating large-scale in vitro functional genomic screen and multi-omics data to identify novel breast cancer targets.

Breast Cancer Res Treat

September 2025

Yale School of Medicine, Yale Cancer Center, 300 George Street, Suite 120, Rm 133, New Haven, CT, 06511, USA.

Purpose: Our goal is to leverage publicly available whole transcriptome and genome-wide CRISPR-Cas9 screen data to identify and prioritize novel breast cancer therapeutic targets.

Methods: We used DepMap dependency scores > 0.5 to identify genes that are potential therapeutic targets in 48 breast cancer cell lines.

View Article and Find Full Text PDF

Interferon-gamma (IFN-γ) is a key regulator of immune responses. A hallmark of IFN-γ responses is inducible nitric oxide (NO), driven primarily by nitric oxide synthase (NOS)2. In this study, we investigated the influence of NO on the IFN-γ-induced transcriptomic and metabolic changes in the RAW 264.

View Article and Find Full Text PDF